A multi-parametric imaging investigation of the response of C6 glioma xenografts to MLN0518 (tandutinib) treatment.
about
Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.Glial progenitors as targets for transformation in glioma.Multi-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancer.Imaging aspects of the tumor stroma with therapeutic implications.Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape.MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment.
P2860
A multi-parametric imaging investigation of the response of C6 glioma xenografts to MLN0518 (tandutinib) treatment.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A multi-parametric imaging inv ...... LN0518 (tandutinib) treatment.
@ast
A multi-parametric imaging inv ...... LN0518 (tandutinib) treatment.
@en
A multi-parametric imaging inv ...... 6 glioma xenografts to MLN0518
@nl
type
label
A multi-parametric imaging inv ...... LN0518 (tandutinib) treatment.
@ast
A multi-parametric imaging inv ...... LN0518 (tandutinib) treatment.
@en
A multi-parametric imaging inv ...... 6 glioma xenografts to MLN0518
@nl
prefLabel
A multi-parametric imaging inv ...... LN0518 (tandutinib) treatment.
@ast
A multi-parametric imaging inv ...... LN0518 (tandutinib) treatment.
@en
A multi-parametric imaging inv ...... 6 glioma xenografts to MLN0518
@nl
P2093
P2860
P1433
P1476
A multi-parametric imaging inv ...... MLN0518 (tandutinib) treatment
@en
P2093
Daniel P Bradley
Jennifer Terkelsen
Jessica K R Boult
Simon Walker-Samuel
P2860
P304
P356
10.1371/JOURNAL.PONE.0063024
P407
P577
2013-04-26T00:00:00Z